BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 24183471)

  • 1. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
    Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P
    Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.
    Preusser M; Berghoff AS; Ilhan-Mutlu A; Magerle M; Dinhof C; Widhalm G; Dieckmann K; Marosi C; Wöhrer A; Hackl M; Zöchbauer-Müller S; von Deimling A; Schoppmann SF; Zielinski CC; Streubel B; Birner P
    Lung Cancer; 2013 Jun; 80(3):278-83. PubMed ID: 23453647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.
    Preusser M; Streubel B; Berghoff AS; Hainfellner JA; von Deimling A; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; Zielinski C; Birner P
    Histopathology; 2014 Nov; 65(5):684-92. PubMed ID: 25039982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.
    Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
    Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
    Schildhaus HU; Heukamp LC; Merkelbach-Bruse S; Riesner K; Schmitz K; Binot E; Paggen E; Albus K; Schulte W; Ko YD; Schlesinger A; Ansén S; Engel-Riedel W; Brockmann M; Serke M; Gerigk U; Huss S; Göke F; Perner S; Hekmat K; Frank KF; Reiser M; Schnell R; Bos M; Mattonet C; Sos M; Stoelben E; Wolf J; Zander T; Buettner R
    Mod Pathol; 2012 Nov; 25(11):1473-80. PubMed ID: 22684217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.
    Sousa V; Reis D; Silva M; Alarcão AM; Ladeirinha AF; d'Aguiar MJ; Ferreira T; Caramujo-Balseiro S; Carvalho L
    Virchows Arch; 2016 Aug; 469(2):173-82. PubMed ID: 27194548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [MRI features of brain metastases of lung cancer].
    Ouyang H; Zhou CW; Zhang HM
    Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):315-8. PubMed ID: 15312374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor gene in primary tumor and metastatic sites from non-small cell lung cancer.
    Daniele L; Cassoni P; Bacillo E; Cappia S; Righi L; Volante M; Tondat F; Inghirami G; Sapino A; Scagliotti GV; Papotti M; Novello S
    J Thorac Oncol; 2009 Jun; 4(6):684-8. PubMed ID: 19404216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH.
    Russell PA; Yu Y; Young RJ; Conron M; Wainer Z; Alam N; Solomon B; Wright GM
    Mod Pathol; 2014 Dec; 27(12):1621-31. PubMed ID: 24762544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
    Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.
    Young RJ; Lim AM; Angel C; Collins M; Deb S; Corry J; Wiesenfeld D; Kleid S; Sigston E; Lyons B; Russell PA; Wright G; McArthur GA; Fox SB; Rischin D; Solomon B
    Oral Oncol; 2013 Jun; 49(6):576-81. PubMed ID: 23434054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.
    Clauditz TS; Böttcher A; Hanken H; Borgmann K; Sauter G; Wilczak W; Grob T; Münscher A
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):53-61. PubMed ID: 29022097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.
    Malchers F; Dietlein F; Schöttle J; Lu X; Nogova L; Albus K; Fernandez-Cuesta L; Heuckmann JM; Gautschi O; Diebold J; Plenker D; Gardizi M; Scheffler M; Bos M; Seidel D; Leenders F; Richters A; Peifer M; Florin A; Mainkar PS; Karre N; Chandrasekhar S; George J; Silling S; Rauh D; Zander T; Ullrich RT; Reinhardt HC; Ringeisen F; Büttner R; Heukamp LC; Wolf J; Thomas RK
    Cancer Discov; 2014 Feb; 4(2):246-57. PubMed ID: 24302556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
    Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
    Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.